Literature DB >> 17366951

A new perspective in diagnosing polycystic ovary syndrome.

Melek Eda Ertorer1, Inan Anaforoglu, Emre Bozkirli, Okan Bakiner, Neslihan Bascil Tutuncu, Nilgun Guvener Demirag.   

Abstract

Recently, the term of "possible" polycystic ovary syndrome (PCOS) has been used for defining cases in which biochemical evaluations are incomplete but clinical phenotypes are suggestive of PCOS. The aim of this study was, by using Rotterdam 2003 criteria, to detect possible PCOS cases and compare their characteristics and insulin sensitivity status with confirmed PCOS subjects. One-hundred-eighteen women who admitted with complaints and symptoms suggesting PCOS were included. Insulin sensitivity status of the cases was calculated with Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). Cases fulfilling Rotterdam 2003 criteria were defined as confirmed PCOS, whereas indeterminate subjects as possible PCOS. Confirmed PCOS was detected in 70 (59.3%) and possible PCOS in 48 (40.7%) cases. Confirmed PCOS was most prevalent among subjects with hirsutism and menstrual dysfunction; 32 (80.0%) vs. 8 (20%), (p=0.000). Body mass index and HOMA-IR values did not differ between groups: confirmed PCOS versus possible PCOS; 25.46+/-5.55 kg/m(2) vs. 26.75+/-7.55 kg/m(2), 3.37+/-4.12 vs. 3.21+/-2.50, (p>0.05). Family history of type-2 diabetes mellifus was similar within both groups (p>0.05). Many PCOS patients seem to be undiagnosed due to inadherence to diagnostic work-up and/or to not fulfill Rotterdam 2003 criteria. These criteria may not be sufficient to cover the entire spectrum of PCOS.

Entities:  

Mesh:

Year:  2007        PMID: 17366951      PMCID: PMC2569430     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  13 in total

1.  Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.

Authors:  Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2006-01-17       Impact factor: 5.958

Review 2.  Clinical review 10: An endocrinologic approach to the patient with hirsutism.

Authors:  D A Ehrmann; R L Rosenfield
Journal:  J Clin Endocrinol Metab       Date:  1990-07       Impact factor: 5.958

Review 3.  Insulin resistance in polycystic ovary syndrome: progress and paradoxes.

Authors:  A M Venkatesan; A Dunaif; A Corbould
Journal:  Recent Prog Horm Res       Date:  2001

4.  Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study.

Authors:  R Azziz; L A Hincapie; E S Knochenhauer; D Dewailly; L Fox; L R Boots
Journal:  Fertil Steril       Date:  1999-11       Impact factor: 7.329

Review 5.  Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span.

Authors:  Ricardo Azziz; Catherine Marin; Lalima Hoq; Enkhe Badamgarav; Paul Song
Journal:  J Clin Endocrinol Metab       Date:  2005-06-08       Impact factor: 5.958

6.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

Review 7.  Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.

Authors:  Fernando Ovalle; Ricardo Azziz
Journal:  Fertil Steril       Date:  2002-06       Impact factor: 7.329

8.  Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.

Authors:  D A Ehrmann; J Sturis; M M Byrne; T Karrison; R L Rosenfield; K S Polonsky
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

10.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.